醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
OCUL · OCULAR THERAPEUTIX, INC
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
OCULAR THERAPEUTIX, INC（OCUL）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $568K；高管董事有效買入 —、有效賣出 —。最近申報 2026-10-13。
買入 Bought—
賣出 Sold$568K
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-08 | Anderman Todd Chief Legal Officer | 賣出 Sell | 11,984 | $7.29 | $87K | SEC |
| 2026-10-02 | Heier Jeffrey S. Chief Scientific Officer | 賣出 Sell | 10,869 | $7.05 | $77K | SEC |
| 2026-10-02 | Kaiser Peter Chief Development Officer | 賣出 Sell | 9,990 | $7.05 | $70K | SEC |
| 2026-08-31 | Notman Donald Chief Operating Officer | 賣出 Sell | 1,099 | $10.24 | $11K | SEC |
| 2026-08-24 | Dugel Pravin Director, See Remarks | 賣出 Sell | 21,649 | $10.77 | $233K | SEC |
| 2026-08-24 | Heier Jeffrey S. Chief Scientific Officer | 賣出 Sell | 3,296 | $10.78 | $36K | SEC |
| 2026-08-24 | Kaiser Peter Chief Development Officer | 賣出 Sell | 3,035 | $10.77 | $33K | SEC |
| 2026-08-24 | Nayak Sanjay Chief Strategy Officer | 賣出 Sell | 1,897 | $10.78 | $20K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-10-08 | Anderman Todd Officer | 11,984 | $87K | |
| 2026-10-02 | Heier Jeffrey S. Officer | 10,869 | $77K | |
| 2026-10-02 | Kaiser Peter Officer | 9,990 | $70K | |
| 2026-08-31 | Notman Donald Officer | 1,099 | $11K | |
| 2026-08-24 | Dugel Pravin Officer | 21,649 | $233K | |
| 2026-08-24 | Heier Jeffrey S. Officer | 3,296 | $36K | |
| 2026-08-24 | Kaiser Peter Officer | 3,035 | $33K | |
| 2026-08-24 | Nayak Sanjay Officer | 1,897 | $20K |
內部人 Insiders
Anderman Todd、Heier Jeffrey S.、Kaiser Peter、Notman Donald、Dugel Pravin、Nayak Sanjay